Neoadjuvant therapy of squamous cell carcinoma of the esophagus: Role of resection and benefit in partial responders
- 1 August 1989
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 48 (2) , 218-221
- https://doi.org/10.1016/0003-4975(89)90073-8
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagusThe Annals of Thoracic Surgery, 1988
- Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junctionCancer, 1988
- Comparison of three treatment strategies for esophageal cancer within a single institutionInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Esophageal carcinoma: modest benefits from combined modality therapy.Radiology, 1987
- Early Results with Combined Modality Therapy for Carcinoma of the EsophagusAnnals of Surgery, 1987
- Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037).Journal of Clinical Oncology, 1987
- Therapeutic alternatives in patients with esophageal cancerThe American Journal of Surgery, 1985